These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 15983231)
1. Evidence of an association between the Arg72 allele of the peptide YY and increased risk of type 2 diabetes. Torekov SS; Larsen LH; Glümer C; Borch-Johnsen K; Jørgensen T; Holst JJ; Madsen OD; Hansen T; Pedersen O Diabetes; 2005 Jul; 54(7):2261-5. PubMed ID: 15983231 [TBL] [Abstract][Full Text] [Related]
2. Studies of the peptide YY and neuropeptide Y2 receptor genes in relation to human obesity and obesity-related traits. Hung CC; Pirie F; Luan J; Lank E; Motala A; Yeo GS; Keogh JM; Wareham NJ; O'Rahilly S; Farooqi IS Diabetes; 2004 Sep; 53(9):2461-6. PubMed ID: 15331560 [TBL] [Abstract][Full Text] [Related]
3. Common neuropeptide Y2 receptor gene variant is protective against obesity among Swedish men. Lavebratt C; Alpman A; Persson B; Arner P; Hoffstedt J Int J Obes (Lond); 2006 Mar; 30(3):453-9. PubMed ID: 16331299 [TBL] [Abstract][Full Text] [Related]
4. Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes. Grarup N; Andersen G; Krarup NT; Albrechtsen A; Schmitz O; Jørgensen T; Borch-Johnsen K; Hansen T; Pedersen O Diabetes; 2008 Sep; 57(9):2534-40. PubMed ID: 18567820 [TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity. Stefan N; Kovacs P; Stumvoll M; Hanson RL; Lehn-Stefan A; Permana PA; Baier LJ; Tataranni PA; Silver K; Bogardus C Diabetes; 2003 Jun; 52(6):1544-50. PubMed ID: 12765968 [TBL] [Abstract][Full Text] [Related]
6. High serum fasting peptide YY (3-36) is associated with obesity-associated insulin resistance and type 2 diabetes. Ukkola OH; Puurunen VP; Piira OP; Niva JT; Lepojärvi ES; Tulppo MP; Huikuri HV Regul Pept; 2011 Oct; 170(1-3):38-42. PubMed ID: 21635925 [TBL] [Abstract][Full Text] [Related]
7. An association between the Trp64Arg polymorphism in the beta3-adrenergic receptor gene and endometrial cancer and obesity. Babol K; Przybylowska K; Lukaszek M; Pertynski T; Blasiak J J Exp Clin Cancer Res; 2004 Dec; 23(4):669-74. PubMed ID: 15743038 [TBL] [Abstract][Full Text] [Related]
8. Peptide YY (PYY) gene polymorphisms in the 3'-untranslated and proximal promoter regions regulate cellular gene expression and PYY secretion and metabolic syndrome traits in vivo. Shih PA; Wang L; Chiron S; Wen G; Nievergelt C; Mahata M; Khandrika S; Rao F; Fung MM; Mahata SK; Hamilton BA; O'Connor DT J Clin Endocrinol Metab; 2009 Nov; 94(11):4557-66. PubMed ID: 19820027 [TBL] [Abstract][Full Text] [Related]
10. Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population. Romeo S; Sentinelli F; Cavallo MG; Leonetti F; Fallarino M; Mariotti S; Baroni MG Int J Obes (Lond); 2008 Mar; 32(3):413-20. PubMed ID: 17912268 [TBL] [Abstract][Full Text] [Related]
12. No association of peptide tyrosine-tyrosine (PYY) gene R72T variant with obesity in the Kampar Health Clinic cohort, Malaysia. Chan PM; Fan SH; Say YH Malays J Nutr; 2011 Aug; 17(2):201-12. PubMed ID: 22303574 [TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population. Moon MK; Cho YM; Jung HS; Park YJ; Yoon KH; Sung YA; Park BL; Lee HK; Park KS; Shin HD Diabet Med; 2005 Sep; 22(9):1161-6. PubMed ID: 16108843 [TBL] [Abstract][Full Text] [Related]
14. Association study of IRS1 gene polymorphisms with type 2 diabetes in south Indians. Bodhini D; Radha V; Mohan V Diabetes Technol Ther; 2011 Jul; 13(7):767-72. PubMed ID: 21612394 [TBL] [Abstract][Full Text] [Related]
15. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. Nordestgaard AT; Thomsen M; Nordestgaard BG Int J Epidemiol; 2015 Apr; 44(2):551-65. PubMed ID: 26002927 [TBL] [Abstract][Full Text] [Related]
16. Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Québec Family Study. Bouchard L; Weisnagel SJ; Engert JC; Hudson TJ; Bouchard C; Vohl MC; Pérusse L J Endocrinol Invest; 2004 Dec; 27(11):1003-9. PubMed ID: 15754730 [TBL] [Abstract][Full Text] [Related]
17. Studies of associations between the Arg389Gly polymorphism of the beta1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects. Gjesing AP; Andersen G; Albrechtsen A; Glümer C; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O Diabet Med; 2007 Apr; 24(4):392-7. PubMed ID: 17335470 [TBL] [Abstract][Full Text] [Related]
18. The insulin receptor substrate-1 Gly972Arg polymorphism is not associated with Type 2 diabetes mellitus in two population-based studies. van Dam RM; Hoebee B; Seidell JC; Schaap MM; Blaak EE; Feskens EJ Diabet Med; 2004 Jul; 21(7):752-8. PubMed ID: 15209769 [TBL] [Abstract][Full Text] [Related]
19. Low serum PYY is linked to insulin resistance in first-degree relatives of subjects with type 2 diabetes. Boey D; Heilbronn L; Sainsbury A; Laybutt R; Kriketos A; Herzog H; Campbell LV Neuropeptides; 2006 Oct; 40(5):317-24. PubMed ID: 17045646 [TBL] [Abstract][Full Text] [Related]
20. Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits. Nielsen EM; Hansen L; Stissing T; Yanagisawa K; Borch-Johnsen K; Poulsen P; Vaag A; Hansen T; Pedersen O J Mol Med (Berl); 2005 May; 83(5):353-61. PubMed ID: 15821902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]